臨床試験機器・補助ソリューション市場：製品タイプ、フェーズ、エンドユース、適応症別-2025-2030年世界予測

臨床試験機器・補助ソリューション市場の2023年の市場規模は42億1,000万米ドルで、2024年には45億8,000万米ドルに達すると予測され、CAGR 8.81％で成長し、2030年には76億2,000万米ドルに達すると予測されています。

臨床試験機器・補助ソリューション市場には、コンプライアンス、効率性、正確性を確保し、臨床試験の実施を促進する様々な必須製品とサービスが含まれます。これには、医療機器、モニタリング機器、ラボ用品、データ管理用ソフトウェアや患者モニタリングシステムなどのITソリューションが含まれます。これらのソリューションの必要性は、臨床試験業務の合理化、データの完全性の向上、患者の安全性の強化という重要なニーズによってもたらされます。その用途は、患者の募集やモニタリングからデータ収集や規制遵守に至るまで、臨床試験の様々な段階に及んでいます。最終用途は主に製薬会社やバイオテクノロジー企業、およびスポンサーに代わって臨床試験を実施するCRO（医薬品開発業務受託機関）です。

この市場の主な成長要因としては、研究開発への投資の増加による臨床試験量の増加、臨床試験の複雑化、高度な機器とソリューションを要求する厳しい規制要件などが挙げられます。さらに、臨床試験機器におけるAIやIoTの統合などの技術的進歩は、遠隔モニタリングを可能にし、リアルタイムのデータ分析を強化することで、大きなビジネスチャンスをもたらします。コストメリットと多様な人口により臨床試験活動が拡大している新興市場には、顕著なビジネスチャンスがあります。現地でのパートナーシップの確立と現地に特化した技術ソリューションへの投資は、こうした機会を生かすために推奨される戦略です。

しかし、新興国市場では先端機器に関連する高コストや不十分なインフラといった課題に直面しており、これが成長を阻害する可能性があります。また、規制の変更や機器の頻繁な更新と検証の必要性も大きなハードルとなっています。モバイルヘルス技術、分散型試験、モジュール型試験ソリューションの革新と研究は、既存の制約を克服し、進化する市場ニーズに対応する可能性を提供する、事業成長の有望分野です。全体として、同市場は急速な技術進化と臨床試験における精度と効率性への要求の高まりを特徴としており、企業が成長ポテンシャルを効果的に獲得するためには、適応力と先見性を備えたアプローチを維持することが極めて重要です。

市場力学：急速に進化する臨床試験機器・補助ソリューション市場の主要市場インサイトを公開

臨床試験機器・補助ソリューション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 新薬や医療機器の安全かつ効果的な使用を判断する必要性
  • 全世界における臨床試験活動のアウトソーシング
  • 臨床試験機器および付帯ソリューションの研究開発活動への投資の増加
• 市場抑制要因
  • クラウドベースの臨床試験ソリューションに関連するデータセキュリティリスク
• 市場機会
  • 医薬品開発と臨床試験に対する政府の取り組みと支援
  • 臨床試験ソリューションにおける人工知能（AI）とデータ分析の統合
• 市場の課題
  • 臨床試験のための国境を越えたロジスティクスの手続きの複雑さ

ポーターの5つの力：臨床試験機器・補助ソリューション市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臨床試験機器・補助ソリューション市場における外部からの影響の把握

外部マクロ環境要因は、臨床試験機器・補助ソリューション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臨床試験機器・補助ソリューション市場における競合情勢の把握

臨床試験機器・補助ソリューション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臨床試験機器・補助ソリューション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臨床試験機器・補助ソリューション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 新薬や医療機器の安全かつ効果的な使用方法を決定する必要がある
    • 世界中で臨床試験活動のアウトソーシング
    • 臨床試験機器および補助ソリューションの研究開発活動への投資の増加
  • 抑制要因
    • クラウドベースの臨床試験ソリューションに関連するデータセキュリティリスク
  • 機会
    • 医薬品開発と臨床試験に対する政府の取り組みと支援
    • 臨床試験ソリューションにおける人工知能（AI）とデータ分析の統合
  • 課題
    • 臨床試験における国境を越えた物流手続きの複雑さ
• 市場セグメンテーション分析
  • 製品：機器リースおよびレンタルサービスにおける補助調達サービスの利用の増加
  • タイプ：生物学的医薬品の製造プロセスにおける臨床試験装置の適用の増加
  • 適応症：消化器疾患を分析するための臨床試験機器に対する需要の高まり
  • フェーズ：薬剤の有効性を評価するためのフェーズIIでの臨床試験機器と補助ソリューションの使用が増加
  • 最終用途：バイオテクノロジーおよび製薬企業における臨床試験機器の適用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臨床試験機器・補助ソリューション市場：製品別

• 装置
  • 画像診断機器
  • 実験装置
• サービス
  • 補助調達サービス
    • 機器リースおよびレンタルサービス
    • 調達
    • 供給と物流
  • データ管理および分析サービス
  • メンテナンスおよび校正サービス
  • 規制およびコンプライアンスサービス
  • サイト監視およびサポートサービス
  • トレーニングおよびコンサルティングサービス
• システム
  • 臨床試験管理システム
  • 電子データキャプチャシステム
  • ランダム化と治験供給管理

第7章 臨床試験機器・補助ソリューション市場：タイプ別

• 生物学的製剤
• 医療機器
• 小分子

第8章 臨床試験機器・補助ソリューション市場フェーズ別

• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第9章 臨床試験機器・補助ソリューション市場：最終用途別

• 学術調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関
• 医療機器企業

第10章 臨床試験機器・補助ソリューション市場適応症別

• 血液疾患
• 心血管疾患
• 中枢神経系と精神障害
• 消化器疾患
• 免疫学
• 感染症
• 代謝障害
• 腫瘍学

第11章 南北アメリカの臨床試験機器・補助ソリューション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の臨床試験機器・補助ソリューション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの臨床試験機器・補助ソリューション市場

• デンマーク
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • RQM+がLibra Medicalを買収
  • Lambda TherapeuticsはMedidataと提携し、データ管理プロセスを自動化および合理化し、臨床試験の効率性を高めます。
  • MednetがiMednet eClinicalプラットフォーム内でDICOMイメージング機能を開始
  • Launch Therapeuticsが臨床試験開発を加速するためにMedidata AI Intelligent Trialsを選択
  • Clinical ink、新規患者の支払いと物流機能に関してMural Healthとの戦略的提携を発表
  • Cloudbyz、臨床調査を効率化し、新しい治療法の発売を加速する画期的な電子データキャプチャソリューションを発表
  • Clario、臨床試験向けクラウドベースの画像ビューアをリリース
  • ClinChoice、CRO買収で事業拡大を継続
  • Suvodaが専用ソフトウェアプラットフォームを発表
  • ヒューマ、臨床試験プラットフォーム拡大のためアルセディスを買収
  • CardieXの子会社ATCORがInvaryantと提携し、先進的な新しいAI医療技術による臨床試験を実現
  • RQM+が臨床試験サービスを開始
  • エジソン・パートナーズが臨床試験情報破壊企業ロカバントへの2,100万米ドルの資金調達ラウンドを主導
  • パレクセル、中国蘇州に臨床試験用品および物流倉庫を開設
  • フィリップス、分散型臨床試験向け12誘導ECGソリューションを発表

企業一覧

• Eurofins Scientific SE
• Veeva Systems Inc.
• Yokogawa Electric Corporation
• United Parcel Service, Inc.
• Thermo Fisher Scientific, Inc.
• Quipment SAS
• Emsere B.V.
• Dassault Systemes SE
• Parexel International Corporation
• Lonza Group Ltd.
• Global Vision Technologies, Inc.
• Oracle Corporation
• Charles River Laboratories International, Inc.
• Axelerist
• Zifo Technologies Private Limited
• B. Braun SE
• Bio-Rad Laboratories, Inc.
• Eppendorf SE
• IQVIA Holdings Inc.
• Almac Group Limited
• Navitas Inc.
• Quanticate International Limited
• Ancillare, LP
• Royal Philips
• MedNet Solutions, Inc.
• Avantor, Inc.
• Myonex, Inc.
• Hitachi, Ltd.

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING & DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT LEASING & RENTAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY & LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MAINTENANCE & CALIBRATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGULATORY & COMPLIANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SITE MONITORING & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY RANDOMIZATION & TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 82. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 84. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 85. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 87. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 129. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 131. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 132. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 134. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 138. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 141. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 143. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 150. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 152. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 159. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 161. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 162. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 168. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 170. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 171. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 177. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 179. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 186. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 188. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 189. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 192. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 194. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 201. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 202. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 204. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 206. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 207. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 210. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 211. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 212. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 213. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 215. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 216. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 220. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 222. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 223. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 224. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 238. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 240. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 241. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 242. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 243. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 244. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 245. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 254. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 263. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOURCING SERVICES, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 272. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 4.21 billion in 2023, expected to reach USD 4.58 billion in 2024, and is projected to grow at a CAGR of 8.81%, to USD 7.62 billion by 2030.

The Clinical Trial Equipment & Ancillary Solutions market encompasses a variety of essential products and services that facilitate the execution of clinical studies, ensuring compliance, efficiency, and accuracy. This includes medical devices, monitoring equipment, lab supplies, and IT solutions such as software for data management and patient monitoring systems. The necessity of these solutions is driven by the critical need to streamline trial operations, improve data integrity, and enhance patient safety. Their application spans various phases of clinical trials, from patient recruitment and monitoring to data collection and regulatory compliance. End-use primarily involves pharmaceutical and biotechnology companies, along with Contract Research Organizations (CROs) that conduct clinical trials on behalf of sponsors.

Key growth influencers in this market include the rise in clinical trial volume driven by increasing investments in R&D, the growing complexity of trials, and stringent regulatory requirements demanding advanced equipment and solutions. Additionally, technological advancements such as the integration of AI and IoT in clinical trial equipment present substantial opportunities, enabling remote monitoring and enhancing real-time data analysis. A prominent opportunity lies in emerging markets where clinical trial activity is expanding due to cost advantages and diverse populations. Establishing local partnerships and investing in localized technology solutions are recommended strategies to capitalize on these opportunities.

However, the market faces challenges such as high costs associated with advanced equipment and inadequate infrastructure in developing regions, which might impede growth. Regulatory changes and the need for frequent updates and validation of equipment also pose significant hurdles. Innovation and research in mobile health technologies, decentralized trials, and modular trial solutions are promising areas for business growth, offering potential to overcome existing limitations and cater to evolving market needs. Overall, the market is characterized by rapid technological evolution and increasing demand for precision and efficiency in clinical trials, making it crucial for businesses to stay adaptive and forward-thinking in their approach to capture the growth potential effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Equipment & Ancillary Solutions Market

The Clinical Trial Equipment & Ancillary Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need to determine the safe and effective use of new drugs and medical device
  • Outsourcing of clinical trial activity across the globe
  • Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
• Market Restraints
  • Data security risks associated with cloud-based clinical trial solutions
• Market Opportunities
  • Government initiatives and support for drug development and clinical trials
  • Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
• Market Challenges
  • Complexities in procedures of cross border logistics for clinical trials

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Equipment & Ancillary Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Equipment & Ancillary Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Equipment & Ancillary Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Equipment & Ancillary Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Equipment & Ancillary Solutions Market

A detailed market share analysis in the Clinical Trial Equipment & Ancillary Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Equipment & Ancillary Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Equipment & Ancillary Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Eurofins Scientific SE, Veeva Systems Inc., Yokogawa Electric Corporation, United Parcel Service, Inc., Thermo Fisher Scientific, Inc., Quipment SAS, Emsere B.V., Dassault Systemes SE, Parexel International Corporation, Lonza Group Ltd., Global Vision Technologies, Inc., Oracle Corporation, Charles River Laboratories International, Inc., Axelerist, Zifo Technologies Private Limited, B. Braun SE, Bio-Rad Laboratories, Inc., Eppendorf SE, IQVIA Holdings Inc., Almac Group Limited, Navitas Inc., Quanticate International Limited, Ancillare, LP, Royal Philips, MedNet Solutions, Inc., Avantor, Inc., Myonex, Inc., and Hitachi, Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management.
• Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.
• Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
• Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies.
• Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
    • 5.1.1.2. Outsourcing of clinical trial activity across the globe
    • 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives and support for drug development and clinical trials
    • 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
  • 5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
  • 5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
  • 5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
  • 5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Equipment & Ancillary Solutions Market, by Product

• 6.1. Introduction
• 6.2. Equipment
  • 6.2.1. Imaging & Diagnostic Equipment
  • 6.2.2. Laboratory Equipment
• 6.3. Services
  • 6.3.1. Ancillary Sourcing Services
    • 6.3.1.1. Equipment Leasing & Rental Services
    • 6.3.1.2. Procurement
    • 6.3.1.3. Supply & Logistics
  • 6.3.2. Data Management & Analysis Services
  • 6.3.3. Maintenance & Calibration Services
  • 6.3.4. Regulatory & Compliance Services
  • 6.3.5. Site Monitoring & Support Services
  • 6.3.6. Training & Consulting Services
• 6.4. Systems
  • 6.4.1. Clinical Trial Management Systems
  • 6.4.2. Electronic Data Capture Systems
  • 6.4.3. Randomization & Trial Supply Management

7. Clinical Trial Equipment & Ancillary Solutions Market, by Type

• 7.1. Introduction
• 7.2. Biologic Drugs
• 7.3. Medical Devices
• 7.4. Small Molecules

8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

• 8.1. Introduction
• 8.2. Phase I
• 8.3. Phase II
• 8.4. Phase III
• 8.5. Phase IV

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Biotechnology & Pharmaceutical Companies
• 9.4. Contract Research Organizations
• 9.5. Medical Device Companies

10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication

• 10.1. Introduction
• 10.2. Blood Disorders
• 10.3. Cardiovascular Diseases
• 10.4. CNS & Mental Disorders
• 10.5. Digestive Disorders
• 10.6. Immunology
• 10.7. Infectious Diseases
• 10.8. Metabolic Disorders
• 10.9. Oncology

11. Americas Clinical Trial Equipment & Ancillary Solutions Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Finland
• 13.4. France
• 13.5. Germany
• 13.6. Israel
• 13.7. Italy
• 13.8. Netherlands
• 13.9. Norway
• 13.10. Poland
• 13.11. Qatar
• 13.12. Russia
• 13.13. Saudi Arabia
• 13.14. South Africa
• 13.15. Spain
• 13.16. Sweden
• 13.17. Switzerland
• 13.18. United Arab Emirates
• 13.19. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. RQM+ Acquires Libra Medical
  • 14.3.2. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
  • 14.3.3. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
  • 14.3.4. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
  • 14.3.5. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
  • 14.3.6. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
  • 14.3.7. Clario Launches Cloud-Based Image Viewer for Clinical Trials
  • 14.3.8. ClinChoice continues expansion with CRO acquisition
  • 14.3.9. Suvoda launches purpose-built software platform
  • 14.3.10. Huma acquires Alcedis to expand clinical trial platform
  • 14.3.11. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
  • 14.3.12. RQM+ Launches Clinical Trial Services
  • 14.3.13. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
  • 14.3.14. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
  • 14.3.15. Philips launches 12-lead ECG solution for decentralized clinical trials

Companies Mentioned

• 1. Eurofins Scientific SE
• 2. Veeva Systems Inc.
• 3. Yokogawa Electric Corporation
• 4. United Parcel Service, Inc.
• 5. Thermo Fisher Scientific, Inc.
• 6. Quipment SAS
• 7. Emsere B.V.
• 8. Dassault Systemes SE
• 9. Parexel International Corporation
• 10. Lonza Group Ltd.
• 11. Global Vision Technologies, Inc.
• 12. Oracle Corporation
• 13. Charles River Laboratories International, Inc.
• 14. Axelerist
• 15. Zifo Technologies Private Limited
• 16. B. Braun SE
• 17. Bio-Rad Laboratories, Inc.
• 18. Eppendorf SE
• 19. IQVIA Holdings Inc.
• 20. Almac Group Limited
• 21. Navitas Inc.
• 22. Quanticate International Limited
• 23. Ancillare, LP
• 24. Royal Philips
• 25. MedNet Solutions, Inc.
• 26. Avantor, Inc.
• 27. Myonex, Inc.
• 28. Hitachi, Ltd.